VNUS Medical Tech - WACC Analysis

VNUS Medical Tech (Weighted Average Cost of Capital (WACC) Analysis)

placeholder_large_analysis.png

Banner%20-%20The%20perfect%20tool%20for%20investors%281%29.gif

Helpful Information for VNUS Medical Tech's Analysis

What is the WACC Formula? Analyst use the WACC Discount Rate (weighted average cost of capital) to determine VNUS Medical Tech's investment risk. WACC Formula = Cost of Equity (CAPM) * Common Equity + (Cost of Debt) * Total Debt. The result of this calculation is an essential input for the discounted cash flow (DCF) analysis for VNUS Medical Tech. Value Investing Importance? This method is widely used by investment professionals to determine the correct price for investments in VNUS Medical Tech before they make value investing decisions. This WACC analysis is used in VNUS Medical Tech's discounted cash flow (DCF) valuation and see how the WACC calculation affect's VNUS Medical Tech's company valuation.

WACC Analysis Information

1. The WACC (discount rate) calculation for VNUS Medical Tech uses comparable companies to produce a single WACC (discount rate). An industry average WACC (discount rate) is the most accurate for VNUS Medical Tech over the long term. If there are any short-term differences between the industry WACC and VNUS Medical Tech's WACC (discount rate), then VNUS Medical Tech is more likely to revert to the industry WACC (discount rate) over the long term.

2. The WACC calculation uses the higher of VNUS Medical Tech's WACC or the risk free rate, because no investment can have a cost of capital that is better than risk free. This situation may occur if the beta is negative and VNUS Medical Tech uses a significant proportion of equity capital.